M Anzà

496 total citations
26 papers, 358 citations indexed

About

M Anzà is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M Anzà has authored 26 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M Anzà's work include Cutaneous Melanoma Detection and Management (11 papers), Virus-based gene therapy research (8 papers) and Sarcoma Diagnosis and Treatment (7 papers). M Anzà is often cited by papers focused on Cutaneous Melanoma Detection and Management (11 papers), Virus-based gene therapy research (8 papers) and Sarcoma Diagnosis and Treatment (7 papers). M Anzà collaborates with scholars based in Italy, United States and India. M Anzà's co-authors include Franco Di Filippo, Carlo Riccardo Rossi, Francesco Cavaliere, Maurizio Vaglini, Mario Lise, Alberto Azzarelli, Claudio Botti, Disma Renda, Simone Mocellin and Pierluigi Pilati and has published in prestigious journals such as Cancer, World Journal of Surgery and Haematologica.

In The Last Decade

M Anzà

25 papers receiving 346 citations

Peers

M Anzà

ONCOL

PRM

SURGE

HEPAT

Yukiko Komano Japan

Tatiana Beresneva United States

Emel Yaman Türkiye

Binder Br Austria

S. Alonso Spain

Stephen J. Murphy United States

J Dunst Germany

Takashi Aikou Japan

Hiroyuki Yamaoka Japan

P Kaemmerlen France

Yukiko Komano Japan

M Anzà

137 ×1.0

ONCOL

63 ×0.6

PRM

138 ×1.6

31 ×0.5

SURGE

39 ×0.6

HEPAT

Citations per year, relative to M Anzà M Anzà (= 1×) peers Yukiko Komano

Countries citing papers authored by M Anzà

Since Specialization

Citations

This map shows the geographic impact of M Anzà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Anzà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Anzà more than expected).

Fields of papers citing papers by M Anzà

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Anzà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Anzà. The network helps show where M Anzà may publish in the future.

Co-authorship network of co-authors of M Anzà

This figure shows the co-authorship network connecting the top 25 collaborators of M Anzà. A scholar is included among the top collaborators of M Anzà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Anzà. M Anzà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Filippo, Franco Di, Patrizio Giacomini, Carlo Riccardo Rossi, et al.. (2009). Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusion.. PubMed. 23(2). 347–52. 16 indexed citations

Giambona, Antonino, et al.. (2008). Significance of borderline hemoglobin A2 values in an Italian population with a high prevalence of -thalassemia. Haematologica. 93(9). 1380–1384. 62 indexed citations

Filippo, Franco Di, Carlo Riccardo Rossi, Mario Santinami, et al.. (2007). Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis.. PubMed. 20(6A). 739–42. 6 indexed citations

Filippo, Franco Di, et al.. (2004). TNFα-Based Isolated Hyperthermic Limb Perfusion (HILP) in the Treatment of Limb Recurrent Melanoma: Update 16 Years after Its First Clinical Application. Journal of Chemotherapy. 16(sup5). 62–65. 3 indexed citations

Filippo, Franco Di, Francesco Cavaliere, M Anzà, et al.. (2004). Liposomal Doxorubicin in the Perfusional Treatment of Advanced Soft Tissue Limb Sarcoma. Journal of Chemotherapy. 16(sup5). 66–69. 7 indexed citations

Natoli, Silvia, et al.. (2004). Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha.. PubMed. 23(2). 225–31. 10 indexed citations

Rossi, Carlo Riccardo, et al.. (2003). Hyperthermic antiblastic perfusion with TNFalpha and melphalan in stage III limb melanoma patients: A phase I - II SITILO study.. PubMed. 22(4 Suppl). 97–101. 2 indexed citations

Cavaliere, Francesco, M Anzà, Carlo Riccardo Rossi, et al.. (2002). [Hyperthermic-antiblastic perfusion in the treatment of tumor of the extremities].. PubMed. 1(3). S35–7. 1 indexed citations

Ferroni, Patrizia, Franco Di Filippo, Francesca Martini, et al.. (2001). Effects of Isolated Limb Perfusion With Tumor Necrosis Factor-α on Circulating Levels of Proinflammatory Cytokines. Journal of Immunotherapy. 24(4). 354–362. 5 indexed citations

10.

Rossi, Carlo Riccardo, Mirto Foletto, Franco Di Filippo, et al.. (1999). Soft tissue limb sarcomas. Cancer. 86(9). 1742–1749. 64 indexed citations

11.

Appetecchia, Marialuisa, Mario Giovanni Chilelli, F. Sciarretta, & M Anzà. (1999). Bilateral Symptomatic Adrenal Myelolipoma. Urologia Internationalis. 62(1). 37–39. 10 indexed citations

12.

Filippo, Franco Di, Carlo Riccardo Rossi, Maurizio Vaglini, et al.. (1999). Hyperthermic Antiblastic Perfusion with Alpha Tumor Necrosis Factor and Doxorubicin for the Treatment of Soft Tissue Limb Sarcoma in Candidates for Amputation. Journal of Immunotherapy. 22(5). 407–414. 23 indexed citations

13.

Cavaliere, Francesco, Franco Di Filippo, Maurizio Cosimelli, et al.. (1999). The integrated treatment of peritoneal carcinomatosis. A preliminary experience.. PubMed. 18(2). 151–8. 3 indexed citations

14.

Filippo, Franco Di, M Anzà, Carlo Riccardo Rossi, et al.. (1998). The application of hyperthermia in regional chemotherapy. Seminars in Surgical Oncology. 14(3). 215–223. 19 indexed citations

15.

Anzà, M, et al.. (1997). Hyperthermic antiblastic perfusion with TNF-Alpha and L.Pam in patients with stage II, IIIA and IIIAB limb melanoma. Melanoma Research. 7(Supplement 1). S32–S32. 4 indexed citations

16.

Filippo, Franco Di, S. Carlini, Pasquale Perri, et al.. (1995). Local hyperthermia and systemic chemotherapy for treatment of recurrent melanoma. World Journal of Surgery. 19(3). 359–362. 9 indexed citations

17.

Cavaliere, R., Francesco Cavaliere, Marcello Deraco, et al.. (1994). Hyperthermic antiblastic perfusion in the treatment of stage IIIA-IIIAB melanoma patients. Comparison of two experiences.. PubMed. 4 Suppl 1. 5–11. 8 indexed citations

18.

Cavaliere, Renato, Franco Di Filippo, Diana Giannarelli, et al.. (1992). Hyperthermic antiblastic perfusion in the treatment of local recurrence or “In‐transit” metastases of limb melanoma. Seminars in Surgical Oncology. 8(6). 374–380. 11 indexed citations

19.

Cosimelli, Maurizio, M Anzà, D Civalleri, et al.. (1991). Two consecutive clinical trials on cisplatin (CDDP), hepatic arterial infusion (HAI), and I.V. 5-fluorouracil (5-FU) chemotherapy for unresectable colorectal liver metastases: An alternative to FUdR-based regimens?. Journal of Surgical Oncology. 48(S2). 63–68. 7 indexed citations

20.

Stipa, S, et al.. (1981). A randomized controlled trial of mesentericocaval shunt with autologous jugular vein.. PubMed. 153(3). 353–6. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact